{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:18:49Z","timestamp":1787980729238,"version":"build-2784847793"},"reference-count":43,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Foundation\u2013Flanders","award":["S008423N"],"award-info":[{"award-number":["S008423N"]}]},{"name":"Research Foundation\u2013Flanders","award":["G029322N"],"award-info":[{"award-number":["G029322N"]}]},{"award":["S008423N"],"award-info":[{"award-number":["S008423N"]}],"id":[{"id":"https:\/\/ror.org\/03qtxy027","id-type":"ROR","asserted-by":"publisher"}]},{"award":["G029322N"],"award-info":[{"award-number":["G029322N"]}],"id":[{"id":"https:\/\/ror.org\/03qtxy027","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004418","name":"Vrije Universiteit Brussel","doi-asserted-by":"crossref","award":["SRP97"],"award-info":[{"award-number":["SRP97"]}],"id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004418","name":"Vrije Universiteit Brussel","doi-asserted-by":"crossref","award":["WFWG-55-22"],"award-info":[{"award-number":["WFWG-55-22"]}],"id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004418","name":"Vrije Universiteit Brussel","doi-asserted-by":"crossref","award":["WFWG-2019"],"award-info":[{"award-number":["WFWG-2019"]}],"id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"crossref"}]},{"award":["SRP97"],"award-info":[{"award-number":["SRP97"]}],"id":[{"id":"https:\/\/ror.org\/006e5kg04","id-type":"ROR","asserted-by":"publisher"}]},{"award":["WFWG-55-22"],"award-info":[{"award-number":["WFWG-55-22"]}],"id":[{"id":"https:\/\/ror.org\/006e5kg04","id-type":"ROR","asserted-by":"publisher"}]},{"award":["WFWG-2019"],"award-info":[{"award-number":["WFWG-2019"]}],"id":[{"id":"https:\/\/ror.org\/006e5kg04","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004744","name":"Innoviris","doi-asserted-by":"publisher","award":["2018POC8"],"award-info":[{"award-number":["2018POC8"]}],"id":[{"id":"10.13039\/501100004744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004744","name":"Innoviris","doi-asserted-by":"publisher","award":["2020POC4"],"award-info":[{"award-number":["2020POC4"]}],"id":[{"id":"10.13039\/501100004744","id-type":"DOI","asserted-by":"publisher"}]},{"award":["2018POC8"],"award-info":[{"award-number":["2018POC8"]}],"id":[{"id":"https:\/\/ror.org\/04af9zr29","id-type":"ROR","asserted-by":"publisher"}]},{"award":["2020POC4"],"award-info":[{"award-number":["2020POC4"]}],"id":[{"id":"https:\/\/ror.org\/04af9zr29","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: Poly(lactic-co-glycolic acid) (PLGA) microparticles are used for sustained drug delivery, yet their final quality depends on both initial droplet formation and the subsequent solvent-extraction-driven droplet-to-particle transition. Microfluidics provides excellent control over precursor droplets, but this control may be partially lost during particle formation. We previously developed dynamic solvent extraction (DSE), in which the droplet-to-particle transition occurs progressively during continuous transport through an extended microfluidic channel. Here, we investigated whether this control improves quality attributes and release of drug-loaded PLGA microparticles. Methods: Dexamethasone (DEX)-loaded PLGA microparticles were produced using DSE or static solvent extraction (SSE), in which microfluidic droplets were transferred to an external aqueous medium for particle formation. Three PLGA concentrations (2.5, 5, and 10% (w\/v)) were investigated, with processing conditions selected to obtain comparable final particle sizes and reduce size as a confounding variable. Results: DSE significantly reduced particle-size coefficient of variation compared with SSE, indicating better preservation of size uniformity. Drug loading and encapsulation efficiency were governed mainly by PLGA concentration, with no significant effect of extraction strategy. Morphological effects were formulation-dependent, with the most pronounced defects in 5% (w\/v) SSE particles. All formulations provided sustained DEX release over 70 days. Although the overall effect of extraction strategy on 24 h burst release was not statistically significant, DSE consistently produced numerically lower burst release, with the largest and most variable burst observed for the morphologically heterogeneous 5% (w\/v) SSE formulation. Conclusions: These findings extend DSE to drug-loaded sustained-release microparticles and identify the solvent-extraction environment as an important determinant of final particle quality.<\/jats:p>","DOI":"10.3390\/pharmaceutics18091075","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:58:21Z","timestamp":1787828301000},"page":"1075","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microfluidic Production of Dexamethasone-Loaded PLGA Microparticles: Dynamic Solvent Extraction Improves Process Robustness During the Droplet-to-Particle Transition"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-2683","authenticated-orcid":false,"given":"Nader","family":"Amanatchi","sequence":"first","affiliation":[{"name":"Unit Diabetes Pathology and Therapy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium"},{"name":"\u00b5Flow Group, Department of Chemical Engineering, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4815-6023","authenticated-orcid":false,"given":"Ilyesse","family":"Bihi","sequence":"additional","affiliation":[{"name":"\u00b5Flow Group, Department of Chemical Engineering, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1571-2233","authenticated-orcid":false,"given":"Matthieu","family":"Briet","sequence":"additional","affiliation":[{"name":"\u00b5Flow Group, Department of Chemical Engineering, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1955-7912","authenticated-orcid":false,"given":"Wim","family":"De Malsche","sequence":"additional","affiliation":[{"name":"\u00b5Flow Group, Department of Chemical Engineering, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9306-4369","authenticated-orcid":false,"given":"Karine H.","family":"Hellemans","sequence":"additional","affiliation":[{"name":"Unit Diabetes Pathology and Therapy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium"},{"name":"\u00b5Flow Group, Department of Chemical Engineering, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.polymer.2015.04.083","article-title":"Formulation of functionalized PLGA polymeric nanoparticles for targeted drug delivery","volume":"68","author":"Crucho","year":"2015","journal-title":"Polymer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled-release systems: Experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/10717544.2021.1943056","article-title":"Poly(lactic-co-glycolic acid) microsphere production based on quality by design: A review","volume":"28","author":"Hua","year":"2021","journal-title":"Drug Deliv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","article-title":"Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation","volume":"304","author":"Park","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rocha, C.V., Gon\u00e7alves, V., da Silva, M.C., Ba\u00f1obre-L\u00f3pez, M., and Gallo, J. (2022). PLGA-Based Composites for Various Biomedical Applications. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042034"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2101536","DOI":"10.1002\/adhm.202101536","article-title":"PLGA\u2019s Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery","volume":"11","author":"Sheffey","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1021\/acs.molpharmaceut.4c00686","article-title":"New Insights on the Burst Release Kinetics of Spray-Dried PLGA Microspheres","volume":"21","author":"Michaelides","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"125822","DOI":"10.1016\/j.ijpharm.2025.125822","article-title":"Elimination of \u201clag\u201d and \u201cburst\u201d phases in drug release profiles of melt-extruded, PLGA-based intravitreal implants","volume":"681","author":"Johnson","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1021\/acsbiomaterials.0c01228","article-title":"Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles","volume":"6","author":"Yoo","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jps.21124","article-title":"Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic)acid microparticle drug delivery systems","volume":"97","author":"Allison","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40204-020-00139-y","article-title":"Recent advances in the formulation of PLGA microparticles for controlled drug delivery","volume":"9","author":"Lagreca","year":"2020","journal-title":"Prog. Biomater."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(02)00136-0","article-title":"Precise control of PLG microsphere size provides enhanced control of drug release rate","volume":"82","author":"Berkland","year":"2002","journal-title":"J. Control. Release"},{"key":"ref_13","first-page":"100440","article-title":"Release mechanisms of PLGA-based drug delivery systems: A review","volume":"10","author":"Siepmann","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2147\/IJN.S445269","article-title":"Microstructure Formation and Characterization of Long-Acting Injectable Microspheres: The Gateway to Fully Controlled Drug Release Pattern","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Han, F.Y., Thurecht, K.J., Whittaker, A.K., and Smith, M.T. (2016). Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00185"},{"key":"ref_16","first-page":"100366","article-title":"Release mechanisms of PLGA microparticles prepared using a microfluidics device or a beaker","volume":"10","author":"Lefol","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lim, Y.W., Tan, W.S., Ho, K.L., Mariatulqabtiah, A.R., Abu Kasim, N.H., Abd Rahman, N., Wong, T.W., and Chee, C.F. (2022). Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030614"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jconrel.2020.10.044","article-title":"Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles","volume":"329","author":"Park","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1039\/C8RA08972H","article-title":"Microfluidic assisted synthesis of PLGA drug delivery systems","volume":"9","author":"Rezvantalab","year":"2019","journal-title":"RSC Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1021\/acs.iecr.9b05935","article-title":"Microfluidic Device for High-Throughput Production of Monodisperse Droplets","volume":"59","author":"Gelin","year":"2020","journal-title":"Ind. Eng. Chem. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfa.2017.05.041","article-title":"Numerical and experimental study of oil-in-water (O\/W) droplet formation in a co-flowing capillary device","volume":"533","author":"Deng","year":"2017","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Fergola, A., Ballesio, A., Frascella, F., Napione, L., Cocuzza, M., and Marasso, S.L. (2025). Droplet Generation and Manipulation in Microfluidics: A Comprehensive Overview of Passive and Active Strategies. Biosensors, 15.","DOI":"10.3390\/bios15060345"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2008.08.015","article-title":"Kinetics of solvent extraction\/evaporation process for PLGA microparticle fabrication","volume":"364","author":"Katou","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-3659(99)00159-5","article-title":"Phase inversion dynamics of PLGA solutions related to drug delivery: Part II. The role of solution thermodynamics and bath-side mass transfer","volume":"62","author":"Brodbeck","year":"1999","journal-title":"J. Control. Release"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"34104","DOI":"10.1063\/1.4738586","article-title":"Droplet based microfluidic fabrication of designer microparticles for encapsulation applications","volume":"6","author":"Kong","year":"2012","journal-title":"Biomicrofluidics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"134885","DOI":"10.1016\/j.colsurfa.2024.134885","article-title":"Advanced microfluidic techniques for in situ PLGA microparticle formation: A dynamic solvent extraction approach","volume":"701","author":"Amanatchi","year":"2024","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1556\/JFC-D-13-00005","article-title":"Microfluidic Solvent Extraction of Metal Ions from Industrial Grade Leach Solutions: Extraction Performance and Channel Aging","volume":"3","author":"Priest","year":"2013","journal-title":"J. Flow Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1039\/c002866e","article-title":"PLGA micro\/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches","volume":"10","author":"Hung","year":"2010","journal-title":"Lab Chip"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2016.08.032","article-title":"Towards a better understanding of the different release phases from PLGA microparticles: Dexamethasone-loaded systems","volume":"514","author":"Gasmi","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0142-9612(01)00291-5","article-title":"Dexamethasone\/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices","volume":"23","author":"Hickey","year":"2002","journal-title":"Biomaterials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10426914.2013.811739","article-title":"Fast Fabrication Process of Microfluidic Devices Based on Cyclic Olefin Copolymer","volume":"29","author":"Azouz","year":"2014","journal-title":"Mater. Manuf. Process."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/elps.200410309","article-title":"Isoelectric focusing in cyclic olefin copolymer microfluidic channels coated by polyacrylamide using a UV photografting method","volume":"26","author":"Li","year":"2005","journal-title":"Electrophoresis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijpharm.2015.10.056","article-title":"In vitro and in vivo performance of dexamethasone loaded PLGA microspheres prepared using polymer blends","volume":"496","author":"Gu","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Barbosa-Alfaro, D., Andr\u00e9s-Guerrero, V., Fernandez-Bueno, I., Garc\u00eda-Guti\u00e9rrez, M.T., Gil-Alegre, E., Molina-Mart\u00ednez, I.T., Pastor-Jimeno, J.C., Herrero-Vanrell, R., and Bravo-Osuna, I. (2021). Dexamethasone PLGA Microspheres for Sub-Tenon Administration: Influence of Sterilization and Tolerance Studies. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020228"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","article-title":"Evaluation of in vivo\u2013in vitro release of dexamethasone from PLGA microspheres","volume":"127","author":"Zolnik","year":"2008","journal-title":"J. Control. Release"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: An add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1080\/10717544.2022.2089297","article-title":"Preparation of uniform-sized GeXIVA [1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency","volume":"29","author":"Li","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/10837450.2011.618948","article-title":"Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres","volume":"18","author":"Yang","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0168-3659(93)90103-C","article-title":"The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery","volume":"25","author":"Scholes","year":"1993","journal-title":"J. Control. Release"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0142-9612(00)00178-2","article-title":"Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction\/evaporation method","volume":"22","author":"Yang","year":"2001","journal-title":"Biomaterials"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2101427","DOI":"10.1002\/adhm.202101427","article-title":"Initial Formation of the Skin Layer of PLGA Microparticles","volume":"11","author":"Sharifi","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1021\/acs.langmuir.6b01799","article-title":"Microporous Polymer Particles via Phase Inversion in Microfluidics: Impact of Nonsolvent Quality","volume":"32","author":"Udoh","year":"2016","journal-title":"Langmuir"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1075\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:47:27Z","timestamp":1787978847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmaceutics18091075"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18091075","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}